151. The Prognostic Value Of Heart-type Fatty Acid Binding Protein In Patients With Acute Coronary Syndrome
- Author
-
Pang Xiao-hua, Wang Hai-long, and Yang Jian-jun
- Subjects
Male ,030213 general clinical medicine ,Acute coronary syndrome ,medicine.medical_specialty ,business.industry ,Myocardial Infarction ,General Medicine ,Publication bias ,Odds ratio ,030204 cardiovascular system & hematology ,Cochrane Library ,Fatty Acid-Binding Proteins ,medicine.disease ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Meta-analysis ,Heart-type fatty acid binding protein ,medicine ,Humans ,Myocardial infarction ,Myocardial infarction diagnosis ,Acute Coronary Syndrome ,business ,Biomarkers - Abstract
The effect of heart-type fatty acid binding protein (H-FABP) remains unclear on the quality of the prognoses of patients with acute coronary syndrome (ACS). The authors searched the EMBASE, PubMed, Cochrane Library, and Medline electronic databases from their respective inceptions throughout June 2017. Odds ratios were pooled from individual studies, and conducted heterogeneity analysis, quality assessment, and publication bias analysis. A total of four studies with 1,994 patients were included (554 positive patients; 1,440 negative patients). Pooled analysis of these studies showed that patients positive for H-FABP had higher incidence for mortality (OR, 6.39; p
- Published
- 2018